ライフサイエンスコーパス: Staphylococcus epidermidis

1 li DH5alpha) and halotolerant cells (such as Staphylococcus epidermidis).

2 r crRNA primary processing and maturation in Staphylococcus epidermidis.

3 n binding protein present in most strains of Staphylococcus epidermidis.

4 the Gram-positive device-associated pathogen Staphylococcus epidermidis.

5 ostridium subterminale, Escherichia coli, or Staphylococcus epidermidis.

6 /- 0.9-fold) on exposure to S aureus but not Staphylococcus epidermidis.

7 d b and strains of Staphylococcus aureus and Staphylococcus epidermidis.

8 timulate growth and formation of biofilms by Staphylococcus epidermidis.

9 ntration on killing of a clinical isolate of Staphylococcus epidermidis.

10 usceptibility to vancomycin in an isolate of Staphylococcus epidermidis.

11 well as Gram-positive Bacillus subtilis and Staphylococcus epidermidis.

12 phenol-soluble modulin, a factor secreted by Staphylococcus epidermidis.

13 also in whole blood cultures stimulated with Staphylococcus epidermidis.

14 is of prosthetic-device infections caused by Staphylococcus epidermidis.

15 gens were Staphylococcus aureus, followed by Staphylococcus epidermidis.

16 S) to type 35 well-characterized isolates of Staphylococcus epidermidis.

17 une responses with Staphylococcus aureus and Staphylococcus epidermidis.

18 a GT-B folded teichoic acid polymerase from Staphylococcus epidermidis.

19 formation is the primary virulence factor of Staphylococcus epidermidis.

20 y to the phenol-soluble modulins (PSMs) from Staphylococcus epidermidis.

21 ould confer protection against S. aureus and Staphylococcus epidermidis.

22 njected with viable Staphylococcus aureus or Staphylococcus epidermidis (1,000 or 500,000 colony-form

23 nic acid resistance and biofilm formation of Staphylococcus epidermidis 1457.

24 ant staphylococci, with S aureus (42.0%) and Staphylococcus epidermidis (20.0%) as the predominant sp

25 en biofilm formation and hemagglutination in Staphylococcus epidermidis, 20 skin isolates and 19 pros

26 am-positive bacteria were isolated in 78.5%; Staphylococcus epidermidis (28.6%) was the most common m

27 Pathogens were Staphylococcus epidermidis (56%), Staphylococcus aureus

28 Common species were Staphylococcus epidermidis (69%), S. warneri (12%), S. h

29 We show that Staphylococcus epidermidis, a commensal bacterium in the

30 Staphylococcus epidermidis, a commensal of humans, secre

31 ity islands have been found in the genome of Staphylococcus epidermidis, a generally less virulent re

32 Staphylococcus epidermidis, a major component of skin fl

33 Staphylococcus epidermidis, a major constituent of the n

34 f all Gram-negative/fungal episodes) whereas Staphylococcus epidermidis accounted for only 1 death (0

35 izing filter (2.1%) became contaminated with Staphylococcus epidermidis after 1 month of treatment, w

36 .01 muM, while the truncated analogue of the Staphylococcus epidermidis AIP-1 (3) elicited an IC50 va

37 A full-length sod gene was cloned from Staphylococcus epidermidis and determined to be more sim

38 haride produced by Staphylococcus aureus and Staphylococcus epidermidis and is an effective target fo

39 esulted in a 1- to 2-log enhanced killing of Staphylococcus epidermidis and other microbes in vitro c

40 acteria, mostly normal skin bacteria such as Staphylococcus epidermidis and Propionibacterium acnes,

41 bodies to target antigen PhnD inhibited both Staphylococcus epidermidis and S. aureus biofilms.

42 hic alpha-helix is inducible within hours by Staphylococcus epidermidis and slowly by another mechani

43 In azithromycin-treated eyes, Staphylococcus epidermidis and Staphylococcus aureus acc

44 Biofilm formation by Staphylococcus epidermidis and Staphylococcus aureus req

45 In Staphylococcus epidermidis and Staphylococcus aureus, a

46 Heat-killed Staphylococcus epidermidis and Staphylococcus aureus, as

47 These infections are commonly caused by Staphylococcus epidermidis and Staphylococcus aureus, bo

48 Staphylococcal bacteria, including Staphylococcus epidermidis and Staphylococcus aureus, ca

49 It also demonstrates potent activity against Staphylococcus epidermidis and Streptococcus spp. (MIC90

50 nce genes (mecA in Staphylococcus aureus and Staphylococcus epidermidis and vanA or vanB in Enterococ

51 The organism-drug combinations were Staphylococcus epidermidis and vancomycin, methicillin-r

52 nst gram-positive (Staphylococcus aureus and Staphylococcus epidermidis) and gram-negative (Escherich

53 in vitro >/= 90% reduction of Gram-positive (Staphylococcus epidermidis) and Gram-negative (Pseudomon

54 the upper airway (Staphylococcus aureus and Staphylococcus epidermidis) and intestinal microbiota (L

55 ates of Staphylococcus aureus, 2 isolates of Staphylococcus epidermidis, and 7 isolates of Staphyloco

56 loodstream, including Staphylococcus aureus, Staphylococcus epidermidis, and Candida albicans.

57 nst Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, and group B Streptococcus.

58 Staphylococcus aureus and Staphylococcus epidermidis are a frequent cause of biofi

59 ections with the leading nosocomial pathogen Staphylococcus epidermidis are characterized by biofilm

60 echanisms of the leading nosocomial pathogen Staphylococcus epidermidis are poorly understood.

61 Staphylococcus aureus and Staphylococcus epidermidis are the leading causes of nos

62 coagulase-negative staphylococci, including Staphylococcus epidermidis, are often considered a conta

63 tive staphylococci, with the leading species Staphylococcus epidermidis, are the predominant cause of

64 and to pathogens Bacillus thuringiensis and Staphylococcus epidermidis, as by the survival rate of t

65 le cells of another Gram-positive bacterium, Staphylococcus epidermidis, as well as of the Gram-negat

66 t in in vitro antibacterial activity against Staphylococcus epidermidis at loadings of silver that ar

67 eudomonas aeruginosa, Bacillus subtilis, and Staphylococcus epidermidis at the single cell and popula

68 a KT2440, Salmonella Typhimurium ATCC 14028, Staphylococcus epidermidis ATCC 12228, Enterococcus faec

69 The camS determinant has homologues in Staphylococcus epidermidis, Bacillus subtilis and Lister

70 rt of the failure of linezolid treatment for Staphylococcus epidermidis bacteremia associated with a

71 Staphylococcus epidermidis belongs to the Type III-A CRI

72 s been implicated as an Escherichia coli and Staphylococcus epidermidis biofilm adhesin, the formatio

73 ucosamine (PNAG) is a major component of the Staphylococcus epidermidis biofilm extracellular matrix.

74 (Aap) mediates cellular accumulation during Staphylococcus epidermidis biofilm maturation.

75 Impedance characterization of Staphylococcus epidermidis biofilms has been performed a

76 electrical current reduced the viability of Staphylococcus epidermidis biofilms in conjunction with

77 ncomycin-resistant Enterococcus faecium, and Staphylococcus epidermidis biofilms.

78 Staphylococcus aureus and Staphylococcus epidermidis both synthesize the surface p

79 mediate-frequency alleles in an arcC gene of Staphylococcus epidermidis, but not in a homologous gene

80 ere also seen with PS/A-producing strains of Staphylococcus epidermidis, but not with transposon muta

81 lling of 10(3)-10(8) colony forming units/ml Staphylococcus epidermidis by 10(5)-10(8) human neutroph

82 trains of Escherichia coli and one strain of Staphylococcus epidermidis by hierarchy cluster analysis

83 d that N-deacetylation of beta-1,6-GlcNAc in Staphylococcus epidermidis by the PgaB homolog, IcaB, an

84 ibited both growth and biofilm production by Staphylococcus epidermidis by up to 55%.

85 examined against Pseudomonas aeruginosa and Staphylococcus epidermidis by varying the dose, the time

86 lebsiella pneumoniae, Staphylococcus aureus, Staphylococcus epidermidis, Candida albicans, and K. kin

87 Here we show that the Staphylococcus epidermidis CRISPR-Cas system can prevent

88 tant Staphylococcus aureus cultures, 9.2% of Staphylococcus epidermidis cultures, and 2.5% of P. aeru

89 ellular adhesin (PIA) in the pathogenesis of Staphylococcus epidermidis CVC-associated infection.

90 PSM was identified as Staphylococcus epidermidis delta toxin, whereas PSM and

91 atment of experimental methicillin-resistant Staphylococcus epidermidis endophthalmitis was evaluated

92 llin-resistant Staphylococcus aureus (MRSA), Staphylococcus epidermidis, Enterococcus faecalis, Acine

93 strains that have been tested, B. subtilis, Staphylococcus epidermidis, Enterococcus faecalis, and E

94 d on surfaces, and belong to species such as Staphylococcus epidermidis, Enterococcus faecalis, Pseud

95 Staphylococcus aureus and Staphylococcus epidermidis ferritin (FtnA and SefA, resp

96 Staphylococcus aureus and Staphylococcus epidermidis form communities (called biof

97 ort on an analysis of sequential isolates of Staphylococcus epidermidis from cultures of blood obtain

98 The glucose transporter from Staphylococcus epidermidis, GlcPSe, is a homolog of the

99 Here, we report the crystal structure of the Staphylococcus epidermidis glucose/H(+) symporter in an

100 The Staphylococcus epidermidis glucose/H(+) symporter is hom

101 rR, a DtxR homologue initially identified in Staphylococcus epidermidis, governs the expression of th

102 Typhimurium (all gram-negative bacteria) and Staphylococcus epidermidis (gram-positive) showed marked

103 hylococcus lugdunensis (groups I and II) and Staphylococcus epidermidis (groups I-III) were sequentia

104 We have discovered an isolate of Staphylococcus epidermidis harboring the genes for thiop

105 A clinical isolate of Staphylococcus epidermidis harbors a CRISPR spacer that

106 Staphylococcus epidermidis harbours a Type III-A CRISPR-

107 Staphylococcus epidermidis has emerged as a causative ag

108 Staphylococcus epidermidis has emerged as an important o

109 In Staphylococcus epidermidis, icaB encodes a deacetylase n

110 ding clinical isolates of MRSA and MSSA) and Staphylococcus epidermidis identified one candidate that

111 The most common organisms identified were Staphylococcus epidermidis in 30.1% (135/448), Streptoco

112 The relationship of initial concentration of Staphylococcus epidermidis in blood cultures and time to

113 isolation of a strictly anaerobic strain of Staphylococcus epidermidis in pure culture from the site

114 es the selective and capacitive detection of Staphylococcus epidermidis in synthetic urine also conta

115 Little is known about the clonality of Staphylococcus epidermidis in the United States, althoug

116 endophthalmitis and revealed the presence of Staphylococcus epidermidis in the vitreous of a culture-

117 factor (STF) and phenol-soluble modulin from Staphylococcus epidermidis induced HIV-LTR trans-activat

118 In particular, colonization with Staphylococcus epidermidis induces IL-17A(+) CD8(+) T ce

119 be effective at reducing both S. aureus and Staphylococcus epidermidis infections in a murine animal

120 nd show that the common blood-borne pathogen Staphylococcus epidermidis influences this in vitro mode

121 Staphylococcus epidermidis is a commensal of human skin

122 The otherwise harmless skin inhabitant Staphylococcus epidermidis is a major cause of healthcar

123 Staphylococcus epidermidis is a major nosocomial pathoge

124 Staphylococcus epidermidis is a skin-resident bacterium

125 Staphylococcus epidermidis is a ubiquitous colonizer of

126 Staphylococcus epidermidis is a well-characterized, nonf

127 Staphylococcus epidermidis is an important human pathoge

128 Staphylococcus epidermidis is an important nosocomial pa

129 Staphylococcus epidermidis is an important opportunistic

130 Staphylococcus epidermidis is an important opportunistic

131 Staphylococcus epidermidis is an opportunistic pathogen

132 Staphylococcus epidermidis is an opportunistic pathogen

133 oteins whose secretion from stationary-phase Staphylococcus epidermidis is dependent on SPase activit

134 Staphylococcus epidermidis is normally a commensal colon

135 Staphylococcus epidermidis is one of the most common cau

136 Staphylococcus epidermidis is one of the primary bacteri

137 Staphylococcus epidermidis is the leading cause of devic

138 Staphylococcus epidermidis is the leading cause of hospi

139 edical devices in hospitalized patients, and Staphylococcus epidermidis is the leading cause of infec

140 The opportunistic human pathogen Staphylococcus epidermidis is the major cause of nosocom

141 Staphylococcus epidermidis is the most frequent cause of

142 Staphylococcus epidermidis is the most frequently isolat

143 , we demonstrated that the saePQRS region in Staphylococcus epidermidis is transcriptionally regulate

144 rs (ME) for daptomycin in an S. aureus and a Staphylococcus epidermidis isolate.

145 s level from the OW (126) and ER (117), with Staphylococcus epidermidis isolates being the most commo

146 Similar proteolytic capacities were found in Staphylococcus epidermidis isolates but not in Staphyloc

147 the species level as containing 203 (73.3%) Staphylococcus epidermidis isolates, 10 (3.6%) Staphyloc

148 Although Staphylococcus epidermidis, Listeria monocytogenes, and

149 valuated whether the commensal microorganism Staphylococcus epidermidis may enhance production of ant

150 sibility, we report the crystal structure of Staphylococcus epidermidis MDD (1.85 A resolution) and,

151 utant (S192A and D283A) ternary complexes of Staphylococcus epidermidis MDD.

152 The BC-GP detected Staphylococcus epidermidis, methicillin-susceptible S. e

153 Staphylococcus epidermidis, Micrococcus luteus, Brevibac

154 y a normal microbial resident of human skin, Staphylococcus epidermidis, might also act as an antimic

155 us aureus (MSSA) (14), methicillin-resistant Staphylococcus epidermidis (MRSE) (17), methicillin-susc

156 endocarditis caused by methicillin-resistant Staphylococcus epidermidis (MRSE) and a rare linezolid-r

157 Methicillin-resistant Staphylococcus epidermidis (MRSE) was recovered over a 2

158 illin-resistant Stapylococcus aureus (MRSA), Staphylococcus epidermidis (MRSE), and Mycobacterium spp

159 ermidis (MRSE) (17), methicillin-susceptible Staphylococcus epidermidis (MSSE) (9), other coagulase-n

160 010, we recovered 38 methicillin-susceptible Staphylococcus epidermidis (MSSE) isolates from endophth

161 were 1 x 108 colony forming units of either Staphylococcus epidermidis (n = 100) or Enterobacter clo

162 Staphylococcus aureus and Staphylococcus epidermidis often elaborate adherent biof

163 = 99); 176 received tail vein injections of Staphylococcus epidermidis on postoperative day (POD) 10

164 The remaining 49 donors had either Staphylococcus epidermidis or other unlikely pathogens r

165 Cultures of Staphylococcus epidermidis or primary human gingival fib

166 cillus actinomycetemcomitans, skin commensal Staphylococcus epidermidis, or skin pathogen Streptococc

167 The most common isolates were Staphylococcus epidermidis, other coagulase-negative Sta

168 After the addition of 10(3) CFU of Staphylococcus epidermidis per ml, aliquots of catheter-

169 Therefore, we investigated the impact of the Staphylococcus epidermidis phenotype on colonization of

170 Staphylococcus aureus and Staphylococcus epidermidis possess a 42-kDa cell wall tr

171 monstrates that quorum-sensing regulation in Staphylococcus epidermidis protects it from key mechanis

172 carditis due to Rhodotorula mucilaginosa and Staphylococcus epidermidis, proven by culture and histop

173 show here that d-lactate dehydrogenase from Staphylococcus epidermidis reduces a broad spectrum of 2

174 Staphylococcus epidermidis releases a group of peptides

175 Staphylococcus epidermidis releases factors that activat

176 The type III-A system in Staphylococcus epidermidis RP62a blocks the transfer of

177 A rabbit model of endophthalmitis induced by Staphylococcus epidermidis (S) was established.

178 cnes, Staphylococcus aureus (S. aureus), and Staphylococcus epidermidis (S. epidermidis) with lauric

179 Several microbes, including Staphylococcus epidermidis (S. epidermidis), a Gram-posi

180 nosa), Staphylococcus aureus (S. aureus) and Staphylococcus epidermidis (S. epidermidis).

181 a significant reduction in viable counts of Staphylococcus epidermidis, Saccharomyces cerevisiae, an

182 DNA fragment was identified and cloned from Staphylococcus epidermidis (Se) using femA from S. aureu

183 ginosa [PA], Staphylococcus aureus [SA], and Staphylococcus epidermidis [SE]) was tested by using Kir

184 in commensal and leading nosocomial pathogen Staphylococcus epidermidis senses and efficiently inacti

185 ecreted polypeptides from the skin commensal Staphylococcus epidermidis, soluble tuberculosis factor

186 ureus-specific femA-SA gene, with absence of Staphylococcus epidermidis specific femA-SE.

187 ng, and wound; the most common isolates were Staphylococcus epidermidis, Staphylococcus aureus, and C

188 gel surface is active against Gram-positive (Staphylococcus epidermidis, Staphylococcus aureus, and S

189 identification of 20 blood-borne pathogens (Staphylococcus epidermidis, Staphylococcus aureus, Bacil

190 Staphylococcus epidermidis, Staphylococcus aureus, coagu

191 s detected by radial diffusion assay against Staphylococcus epidermidis, Staphylococcus aureus, Esche

192 At 1 to 10 CFU/ml, Escherichia coli, Staphylococcus epidermidis, Staphylococcus aureus, Liste

193 The most common species detected were Staphylococcus epidermidis, Staphylococcus hominis, and

194 A catalase-negative Staphylococcus epidermidis strain was recovered from bot

195 documented isolation of a strictly anaerobic Staphylococcus epidermidis strain, confirmed by rpoB gen

196 The relative abundance of three Staphylococcus epidermidis strains, as well as three pha

197 hicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis strains.

198 ve bacterial species (Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, En

199 lanB) which have substantial homology to the Staphylococcus epidermidis structural gene (epiA) and a

200 y expressed repeats of the AtlE amidase from Staphylococcus epidermidis suggest that the repeating se

201 y related accumulation-associated protein of Staphylococcus epidermidis, suggesting the possibility o

202 mmation initiated by a single application of Staphylococcus epidermidis supernatant, correlating with

203 In Staphylococcus epidermidis, target/crRNA mismatches at s

204 SdrG is a cell wall-anchored adhesin from Staphylococcus epidermidis that binds to the Bbeta chain

205 the growth of both Staphylococcus aureus and Staphylococcus epidermidis, the latter were unable to el

206 ntified as Staphylococcus lugdunensis (one), Staphylococcus epidermidis (three), Staphylococcus haemo

207 ght to be a crucial factor in the ability of Staphylococcus epidermidis to produce a biomaterial-base

208 We show that in the Staphylococcus epidermidis type III CRISPR-Cas system, m

209 that transcription across the targets of the Staphylococcus epidermidis type III-A CRISPR-Cas system

210 Here we show that targeting by the Staphylococcus epidermidis type III-A CRISPR-Cas system

211 inetobacter and Moraxella species (type II), Staphylococcus epidermidis (type III), Porphyromonas and

212 ms from the primary broth culture other than Staphylococcus epidermidis, viridans group streptococci,

213 oll-like receptors with Candida albicans and Staphylococcus epidermidis was 2.5- and 2.9-fold higher

214 hermic preservation by investigating whether Staphylococcus epidermidis was capable of growing in a s

215 miting the spread of conjugative plasmids in Staphylococcus epidermidis was first described in 2008.

216 Staphylococcus epidermidis was the predominant isolate (

217 Staphylococcus epidermidis was used as the model target

218 ated catheters from studied patients against Staphylococcus epidermidis was used to determine the ant

219 ysiology of the leading nosocomial pathogen, Staphylococcus epidermidis, we analyzed the genome of bi

220 n beta-defensin 3 in the nosocomial pathogen Staphylococcus epidermidis, we discovered an antimicrobi

221 As has been shown previously in Staphylococcus epidermidis, we found that IcaR was also

222 e ligands for E. coli, Citrobacter freundii, Staphylococcus epidermidis were 100%, 2.6% and 8.6% resp

223 Fibrin gels (1500 microm thick) containing Staphylococcus epidermidis were formed in Boyden-type ch

224 ein fractions from Staphylococcus aureus and Staphylococcus epidermidis, were able to distinguish bet

225 Culturing Staphylococcus epidermidis with a low concentration of t

226 h of the pathogens Staphylococcus aureus and Staphylococcus epidermidis with comparable IC(50) to van

227 ynebacterium glutamicum, Microcuccus luteus, Staphylococcus epidermidis, Yersinia ruckeri, Escherichi